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I. Setting Parameters?
On November 20, 2007, independent teams of researchers in Wisconsin and
Japan announced the achievement of a scientific advancement which, over time, may
well force a conclusion of the long standing debate on whether embryonic stem cell
research is "appropriate" morally.' Specifically, these scientists created human
embryonic stem cells from human skin cells, without destroying any human embryos.
2
The hope is that, in due course, these new cells could yield eventually the very same
medical promise as embryonic stem cells being developed, as such, to treat heart disease,
diabetes, and Parkinson's, and also to create heart and nerve tissue.
3
When this technique was presented for discussion at a meeting sponsored by
the Vatican, a spokesman stated that there was "no moral problem with it at all.''4 The
chief domestic policy adviser to President George W. Bush observed that this new
scientific achievement held the promise of allowing medical progress without
* Professor of Law, The Catholic University of America, Washington, DC; B.S., J.D., Indiana
University; LL.M. Columbia University; LL.D., Indiana University.
I Rick Weiss, Advance May End Stem Cell Debate: Labs Create a Stand-In Without Eggs, Embryo,
WASH. POST, Nov. 21, 2007, at Al.
2Id.
3 Gautam Naik, Advance in Stem-Cell Work Avoids Destroying Embyos, WALL ST. J., Nov. 21, 2007, at
Al.
4 Rick Weiss, Advance May End Stem Cell Debate: Labs Create a Stand-In Uithont Eggs, Embgo,
WASH. POST, Nov. 21, 2007, at A4 (quoting Richard Doerflinger of the U.S. Conference of
Catholic Bishops).
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compromising moral standards. 5 Indeed, this new laboratory success shows "science
has overtaken politics" and that real progress can be achieved without having "a culture
war."
6
Others in the scientific community are quick to remind that this level of medical
research, while indeed promising, could take many years before it could be used
clinically and applied to humans. Accordingly, they urge a continuation of research and
experimentation in all other "traditional" areas of stem cell research. And, this
continuation means that the ethical and moral issues surrounding legal status of embryos
remain in play.
7
Earlier in November 2007, another new stem cell research achievement was
recorded when a group of Oregon scientists announced that they have not only created,
but harvested, stem cells from fully formed monkey embryos. 8 As such, this success
becomes a world-wide "first." Created from a skin cell from a single monkey, this
research validates what has heretofore been subject to wide speculation: namely,
whether primates are capable of being cloned biologically. 9 The scientists undertaking
this research did not transfer the embryos which were created to the wombs of female
monkeys with the purpose of growing them into full-blown clones as has been done
with other species (e.g., mice). Rather, the Oregon experiment merely retrieved,
successfully, embryonic stem cells from the embryos. 10
Although this research was limited, specifically, to the development of stem
cells, concerns have been raised that this cloning technique could be applied to
humans." Indeed, this scientific achievement could well re-ignite the on-going
congressional debate over the extent to which restrictions on the cloning of human
embryos should be either loosened further or tightened. While no legal restrictions have
been imposed for private work here, federally funded scientists are prohibited from
engaging in research of this nature. 
12
5 Michael Abramowitz & Rick Weiss, A Scietific Advance, a PoliticalQuestion Mark, WASH. POST,
Nov. 21, 2007, at A4.
6 Id.
7 Id. See generally Thomas B. Okarma, Hunman Primordial Stem Cells, 29 HASTINGS CTM. RPT. 30
(1999) (discussing the debate surrounding the use of human stem cells).
8 Rick Weiss, Monkey Embiyos Cloned from Stem Cells, WASH. POST, Nov. 15, 2007, at Al.
9 Id.
10 Id.
1 Id. (reporting on the concern of Rev. Thomas Berg, Executive Director, The Westchester
Institute).
12 Rick Weiss, Mlonkey Embr, os Clonedfrom Stem Cells, WASH. POST, Nov. 15, 2007, at Al.
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This scientific achievement in Oregon must be added to other equally path
breaking ones which seek to perfect human cloning, 13 create designer pathogens, 14
develop more fully in vitro fertilization and other forms of assisted reproduction, 15 and to
perfect organ transplantation, 16 face 17 and womb transplants, s cryogenic preservation
pre or post mortem,19 genetic enhancement through eugenic experimentation, 20 and
genetically modified genes and foods designed, as such, to enrich and prolong a life
resistant to disease.2'1 Additionally, a new dimension was added to what has been
become known as the "New Medicine" 22 when, in September 2007, the British Human
Fertilization and Embryo Authority ruled that it was proper for part-human-part-animal
embryos, termed chimeras, to be developed and used in medical experimentation. 23 This
particular scientific option is a source of considerable concern for some because it is
feared that some hybrid embryos could be transferred, illegitimately, to wombs of
13 K.L. MACINTOSH, ILLEGAL BEINGS: HUMAN CLONES AND THE LAW (Cambridge Univ. Press,
2005) (2006).
14 See Moss & Jamieson, 50m pound Research to Create Revolutionagy PersonalirZed Drugs, THE DAILY
TELEGRAPH, April 4, 2006, at 5. See generaly REPROGENETICS: LAW, POLICY AND ETHICAL
ISSUES (L.P. Knowles & G.E. Kaebnick eds., The Johns Hopkins Univ. Press 2007); THE
FOUNTAIN OF YOUTH: CULTURAL, SCIENTIFIC, AND ETHICAL PERSPECTIVES ON A BIOMEDICAL
GOAL (Stephen G. Post & Robert H. Binstock eds., Oxford Univ. Press 2004).
15 DEBORAH L. SPAR, THE BABY BUSINESS: How MONEY, SCIENCE, AND POLITICS DRIVE THE
COMMERCE OF CONCEPTION (Harvard Bus. Sch. Press 2006). See general# Symposium, Current
Status of Assisted Reproduction Technology 2005: An Overview and Glance at the Future, 39 FAM. L.Q.
573 (2005).
16 R. Rhodes, Justice in Transplant Organ Allocation, in MEDICINE AND SOCIAL JUSTICE ESSAYS ON
THE DISTRIBUTION OF HEALTH CARE at 350. (Rosamand Rhodes, Margaret P. Battin, & Anita
Silvers eds. 2002).
17 Rhonda Gay Hartman, Face Value: Challenges of Transplant Technology, 31 AM. J. L. & MED. 7
(2005); Angela Doland, Face Transplant Recipient Meets Cameras, Questions, WASH. POST, Feb. 7,
2006, at A17; Rich Weiss, Face-Transplant Patient 'Saisfied, WASH. POST, Dec. 13, 2007, at A22.
18 Rob Stein, First U.S. Uterus Transplant Planned, WASH. POST, Jan. 15, 2007, at AL.
19 GEORGE P. SMITH, II, MEDICAL LEGAL ASPECTS OF CRYONICS: PROSPECTS FOR
IMMORTALITY (Associated Faculty Press 1983); George P. Smith, II, Pathways to Immortality in The
New Millennium: Human Responsibilty, Theological Direction, or Legal Alandate, 15 ST. LOUIS U. PUB. L.
REV. 447, 459 (1996).2 0 EDWIN BLACK, WAR AGAINST THE WEAK: EUGENICS AND AMERICA'S CAMPAIGN TO
CREATE A MASTER RACE (Four Walls Eight Windows 2003); George P. Smith, II, Eugenics and
The Family: Exploring The Yin and The Yang, 8 UNIV. OF TASMANIA L. REV. 4 (1984).
21 FINN BOWRING, SCIENCE, SEEDS, AND CYBORGS: BIOTECHNOLOGY AND THE
APPROPRIATION OF LIFE (2003).
2- ALBERT R. JONSEN, THE NEW MEDICINE AND THE OLD ETHICS (Harvard Univ. Press 1990).
23 Rick Weiss, Britain to Allow Creation of Hbrid Embos, WASH. POST, Sept. 6, 2007, at A11.
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women where they might well develop. 24 Present British regulations required all
"human" embryos used in research to be destroyed within fourteen days after their
creation.
25
A significant part of contemporary bioethics, under which the complex ethical,
philosophical, socio-legal and medical issues of the New Medicine are presented, 26 has
been seen as being "biopolitic" in that it has become "embryocentric" 27-this, because
of limitations on federal funding for human embryonic stem cell research. 28 Rather than
develop policy that is viewed as part of a national "political agenda" designed to limit
embryonic research to pre-existing stem cell lines, it is argued that policies should be
developed and pursued which seek to advance liberal care for the present millions of
uninsured Americans and one which thereby work to achieve respect and dignity for all
people-not just embryos.
29
Regrettably, scientific issues become-inevitably-political issues because of
one principle fact: they put in focus the extent to which the government can restrict
private medical research undertakings-either in the name of generational safety,
morality or the public good. 30 The multiple and varied concerns of applying the New
Medicine, derived as such from the New Biology, conduce--essentially-to a suspicion
"continued reductionism in the biological analysis of humans will erode the notions of
autonomy, dignity and personal integrity that have traditionally justified the




26 See generaly GEORGE P. SMITH, II, BIOETHICS AND THE LAW: MEDICAL, SOCIO-LEGAL AND
PHILOSOPHICAL DIRECTIONS FOR A BRAVE NEW WORLD (Lanham ed., University Press of
America) (1993).
27 Id.
28 George J. Annas, Boston University Lecture, American Bioethics After Nuremberg: Pragmatism,
Politics and Human Rights, (2005), at http://www.publichealth.pitt.edu/supercourse/
SupercoursePPT/30011-31001/30701-30801.pdf, (October 2005), at 13. See generally George P.
Smith, II, Biomedicine and Bioethics: De Lege Lata, De Lege Ferenda, 9 J. CONTEMP. HEALTH L. &
POL'Y 233, 254-55 (1993).
29 George J. Annas & Sherman Elias, Politics, Morals and EmbDos, 431 NATURE 19, 19-20 (Sept.
2, 2004) aailable at http://genetics.live.radicaldesigns.org/downloads/
20040902_natureannaselias.pdf.
30 See generally George P. Smith, II, Distbutive Justice and Health Care, 18 J. CONTEMP. HEALTH L.
& POL'Y 421, 421-22 (2002).
1 Sheila Jasanoff, Biology and The Bill of R'gbts: Can Science Reframe The Constitution?, 13 AM. J.L. &
MED. 249 (1990).
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II. The American Ideal
There is a strong, lingering sense-if indeed nothing less than a magnificent
obsession-that the new powers of medical technology may narrow if not blunt the very
meaning of the American ideal which promotes the right to live in a free society and to
pursue happiness. 32 The fundamental concern, then, becomes to what degree of
usefulness is there in pursuing goals beyond therapy towards genetic enhancement.
33
Are there, in other words, limits to the right of scientific investigation? 34 And, if there
are, what are they?35 Finally, is there a standard of "genetic responsibility" 36 that should
be either self-imposed or set by society upon those working in the field-this, even
though such a responsibility may very well be viewed as an unnecessary burden on the
freedom of scientific inquiry?
37
Medical technology is so uniquely powerful that its impact is felt not only in
daily life but in the way life is viewed. For example, the technology of mechanical
ventilators, combined with heart transplantation, brought a societal re-examination of
how death should be defined and led to the conclusion that the death of the entire brain
is equivalent to, for all purposes, death of the whole person. This new definition, in
turn, allowed the "harvesting" of hearts and other vital organs from individuals who-
although dead under a brain death criteria-continued to have both circulation and
32 
PRESIDENT'S COUNCIL ON BIOETHICS, BEYOND THERAPY: BIOTECHNOLOGY AND THE
PURSUIT OF HAPPINESS xviii (2003).
33 Id. at 277. It has been suggested that genetic enhancement should not be viewed as part of
basic health care entitlements and, thus, should be excluded from the domain of distributive
justice. Id. ALLEN BUCHANAN, ET AL., FROM CHANCE TO CHOICE: GENETICS & JUSTICE, 17,
129 (Cambridge University Press 2000); see Leon Kass, The Pursuit of Biohappiness, WASH. POST,
Oct. 16, 2003, at A25; see also George P. Smith, II & Thaddeus J Burns, Genetic Determinism or
Genetic Discrimination, 11 J. CONTEMP. HEALTH L. & POL'Y 23, 30-31 (1994).
34 See George P. Smith, II, Setting Limits: Medical Technology and The Law, 23 SYDNEY L. REV. 283,
(2001).
35 Id; see also George P. Smith, II, The Province and Function of Law, Science, and Medicine: Leewajs o/
Choice and Patterns of Discourse, 10 U. NEW So. WALES L. J. 103 (1987). But see AP, Rules Are
Clarified to Spur MedicalAdvances, N.Y. TIMES, Jan. 31, 2003, at A23 (reporting on how the Food
and Drug Administration has clarified, and some claim relaxed, its requirements for approval of
research on new products).
36 PHILIP KTCHER, THE LIVES TO COME: THE GENETIC REVOLUTION AND HUMAN
POSSIBILITIES 204 (Simon & Schuster 1996).
31 George P. Smith, II, Toward an International Standard of Scentfic Inqui y, 2 HEALTH NL TR X 167,
169-70, 174-75, 189-91 (1992).
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respiration maintained artificially by medical ventilation. 38
While Americans might decide to limit "halfway" or exotic, science-fiction
inspired technologies, such as artificial hearts or brain transfers into robot bodies, it
would appear unlikely they would ever approve limitations on medical research whose
focus is to discover technologies, drugs, and scientific techniques that not only maintain
qualitative existence but extend life.39 The reason for this position is simple and direct:
"there is no coherent argument for arbitrarily ending a life that could be prolonged with
reasonable quality at a reasonable price." 40
Since the end of this century, the public has been almost overwhelmed with
scientific information regarding the genome, the complexities of gene therapy and stem
cell research. 41  Yet to come will be efforts to grow certain tissues for grafting-
including skin, bladder and cartilage. Reportedly, cultured cells have been used
successfully in an experimental setting to treat stroke victims; and in 2006 it was
reported that seven children and teenagers had new implanted bladders grown from
their own muscle and bladder cells.
42
It is expected that the use of similar cells can be used to treat other disabling
38 GEORGE J. ANNAS, STANDARD OF CARE: THE LAW OF AMERICAN BIOETHICS 253 (Oxford
University Press 1993). See Rob Stein, FDA Approves Artifidal Heart for Those Awaiting Transplant,
WASH. POST, Oct. 19, 2004, at A3. See general4, GEORGE P. SMITH, II, THE NEW BIOLOGY:
LAW, ETHICS AND BIOTECHNOLOGY (Plenum Press 1989).
39 See George P. Smith, II, The Frankenstein Myth and Contemporag, Experimentation: Spectre, Legacy,
Curse or Imperative, 2 BIOLAW 5463 (1990). But see Mooney, Nothing Wrong N'ith a Little
Frankenstein, WASH. POST, Dec. 1, 2002, at BI. The science of creating cyborgs-"individuals"
with electronically powered legs, arms, hands and eyes,-is progressing rapidly. Highfield &
Joyce, We Can Rebuild Him. We Have the Techmolog. Almost, THE DAILY TELEGRAPH, April 4,
2006, at 5; Brown, For 1' Woman With Bionic Arm, a New L4fe Is Vithin Reach, WASH. POST, Sept.
14, 2006, at Al.
40 Annas, supra note 38, at 216. See ALBERT R. JONSEN, BIOETHICS BEYOND THE HEADLINES:
WHO LIVES? WHO DIES? WHO DECIDES? (Rowman & Littlefield Publishers, Inc., 2005). See
generally, George P. Smith, II, Utiiy and The Prinple of Medical Futilioy: Safeguarding Autonomy and
The Prohibition Against Cruel and Unusual Punishment, 12 J. CONTEMP. HEALTH L. & POL'Y 1 (1995).
41 See ARTHUR L. CAPLAN, AM I MY BROTHER'S KEEPER?: THE ETHICAL FRONTIERS OF
MEDICINE, Ch. 17 (Indiana University Press 1997). See also Michael D. Kirby, Through the lWorld's
Eye (2000); George P. Smith, II, Harnessing The Human Genome Through L gislative Constraint, 5
EUROP. J. HEALTH L. 53 (1998); George Carr, Suney: The Human Genome, THE ECONOMIST, July
1, 2000, at 54.
42 Atala, Bauer, Soker et al., Tissue-engineered Autologous Bladders for Patients Needing CystoplastY, 361
THE LANCET 1241 (April 15, 2006). See generaly George P. Smith, II, Genetic Enhancement
Technologies and the New Sodety, 4 MED. L. INT'L 85 (2000).
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brain diseases. Genomics-derived drugs hold the potential to expand greatly the range of
treatments achievable with human cells-this, because of their ability to control the cells
as they grow and specialize. 43 Even more opportunities for regenerative medicine will
be charted when the insights from the clonal experiment with Dolly the sheep are
realized first with a re-set of the genetic clock inside a cell and, subsequently, without the
need for egg cells.
44
Essentially, all efforts to achieve justice in the distribution of health care
resources of the New Medicine are utilitarian in character and definition.45 Since these
resources are not infinite, they cannot be offered to or used by everyone. This, of
necessity, then forces choices between those individuals and among groups seeking their
use. Allowing improper distribution of these scarce resources is not only inefficient, it is
wasteful.
46
For utilitarians, the general good is seen as superior to personal goal
satisfaction. 47 Because of the difficulty in calculating the net good deriving from a
utilitarian approach to decision making, 48 some have argued that this approach to health
care decision making is not only unjust but unfair.49 Not only is utilitarianism viewed as
41 William A. Haseltine, Genomics: The Path Ahead for Science, Medicine and Sociey, 19(1) BROOKINGS
REV. 23 (2001). See also Caplan & Magnus, New Life Forms: New Threats, New Possibilities, 33
HASTINGS CTR. RPT. 7 (2003); Commoner, Unraeling the DNA Myth: The Spurious Foundation of
Genetic Engineerin, HARPERS MAG., at 39, 47 (Feb. 2002) (cautioning that the potential
consequences of transferring a DNA gene between species before the consequences of its release
are fully understood is problematic); Rich Weiss, Synthetic DNA on the Brink of Yielding New Life
Forms, WASH. POST, Dec. 17, 2007, at Al (detailing the scientific progress in handcrafting a
chromosome which, in turn, contains the basic instructions for a microbe to live and reproduce,
and the plans to transplant it, subsequently, into a cell which will have the ultimate effect of re-
writing the genetic codes for developing new medicine, fuels and novel chemicals, and, ultimately,
hold the potential for mischief, as well).
44 Id See sapra notes 1-3. See also CHET FLEMING, IF WE CAN KEEP A SEVERED HEAD ALIVE...
: DISCORPORATION AND U.S. PATENT 4,666,425 (Polinym Press 1988); George P. Smith, II,
Intimations of Immortality: Clones, Qyons and the Law, 6 UNIV. NEW SO. WALES L. J. 119 (1983);
Robert Bahr, A New EthicalQuestion: Head Transplants?, 81 SCIENCE DIG. 76 (1977). See generaly,
George J. Annas, The Man on The Moon, Immortait, and Other Millennial Myths: The Prospects and
Perils of Human Genetic Engineering, 49 EMORY L.J. 753 (2000).
41 Hiyry, Utilitarian Approaches to Justice in Health Care, in MEDICINE AND SOCIALJUSTICE: ESSAYS
ON THE DISTRIBUTION OF HEALTH CARE 53 (R. Rhodes, M. P. Battin & A. Silvers eds., Oxford
University Press 2002).
46 Id.
4 See id. at 53, 62.
4sSee id at 54.
49 See Hayry, supra note 45, at 54.
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cold and calculating, but it is seen as denying the individual of what is his due. 51 The
needs of those who are worse off are either ignored or neglected.5'
III. Participatory Democracy
It is a noble sentiment that "active liberty refers to a sharing of a nation's
sovereign authority among its people,"5 2 and is tied-out of necessity-to connecting
frameworks grounded in responsibility, participation and capacity.5 3 The hard reality is
that ordinary individuals have little interest in considering complex policy issues and
have little aptitude for evaluating complex intellectual matters, 54 especially those
involving medical science. 55 Consequently, it is unrealistic to expect either sound and
thoughtful ideas or sensible and understandable policies to be shaped in public
discourses under present conditions of "intellectual disorder." 56 Because of this state,
the scientific community is understandably reluctant to accept public oversight and
direct participation in regulating the parameters of the new biotechnology and its
offspring, the new medicine.5 7 It is important to remember that even though "[s]cience
promises an unpredictable future, . . . futures are inevitably unpredictable."
58
Accordingly, it is well to understand that "doing nothing has just as many consequences
as doing something.
'5 9
50 Hiyry, supra note 45, at 54.
51 Hdyry, supra note 45, at 54. Utilitarian logic does not discount the life of the individual, but
instead balances the interest of one individual against the interests of other individuals. GERALD
R. WINSLOW, TRIAGE AND JUSTICE 83 (University of California Press 1982) (relying on ideas of
Joseph Fletcher). It has been argued that explicit quantifiable utilitarian principles, together with
decision analysis, should be applied by bioethicists in reaching ethical judgments. See JONATHAN
BARON, AGAINST BIOETHICS 5 (Basic Bioethics Series, MIT Press 2006).
52 STEPHEN BREYER, ACTIVE LIBERTY: INTERPRETING OUR DEMOCRATIC CONSTITUTION 15
(Alfred A. Knopf 2005).
53 Id. at 16.
54 See RICHARD A. POSNER, LAW, PRAGMATISM, AND DEMOCRACY 107 (Harvard University
Press 2003).
55 See William J. Broad & James Glanz, Does Science Matter?, N.Y. TIMES, Nov. 11, 2003, at Fl
(commenting on inability of most Americans to endorse scientific rationality).
56 POSNER, supra note 54, at 107. This situation is more understandable when it is realized that
half of the U.S. population has an IQ below 100. Id; see RICHARD J. HERRNSTEIN & CHARLES
MURRAY, THE BELL CURVE: INTELLIGENCE AND CLASS STRUCTURE IN AMERICAN LIFE 276
(Free Press 1994); see also HERRNSTEIN & MURRAY, supra, at 29-91, 269-369
57 See Maureen L. Condic & Samuel B. Condic, The Appropriate Limits of Science in the Fomiation of
Pub'c Pohic, 17 NOTRE DAME J.L. ETHICS & PUB. POL'Y 157, 167 (2003).
58 Owen D. Jones & Timothy H. Goldsmith, Law and Behavioral Biology, 105 COLUM. L. REV. 405,
499 (2005).
59 FRANCIS MACDONALD CORNFORD, MICROCOSMOGRAPHIA ACADEMIA 9 (Bowes & Bowes
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Such a state of affairs means that there can be no direct way to move from any
level of moral assessment to a clear public policy. Instead, all that can be expected is
that a level of information will be provided. Quite often then, owing to a failure to
develop adequately the moral dimensions of formulating public policy in a liberal
pluralistic society, presumptions in favor of reproductive autonomy and scientific
freedom, for example, are indulged and, indeed, advanced.
60
Driven by "painful technologies and sciences," the new medicine runs the risk
of being seen as no longer "patient based." 61 The ideal of philosophical reasoning and
meanings for such ethical terms as responsibility, rights, duties, interests, beneficence
and justice is mired often in confusion and conjecture. 62 Indeed, many of the new
ethical questions raised from the development and practice of the new medicine are set
within a "blurred outline." 63 Perhaps all that can be hoped for is that the Cartesian
aspiration of reaching a "clear and distinct idea" be pursued with objectivity.64 And,
from this may well come acceptance of a societal obligation not to achieve all the good
that can be achieved, but-rather-to effect all the good that can be done within the
limits morality imposes upon the development and use of the technologies of the new
medicine.
65
Although, traditionally, the ethics of medicine has focused on the obligations of
physicians to their individual patients, there is-as well-a need to appreciate broader
ethical issues arising from a recognition that medicine "is always practiced within a social
context." 66  "Social medicine" or, alternatively, "the medicine of society," becomes
crucial to shaping the parameters of application and use in the Age of The New
Publishers, Ltd., 6th ed. 1964) (1908); see Michael D. Kirby, Seven Ages of a Layer, 26 MONASH U.
L. REv. 1, 10 (2000).
60 See George P. Smith, II, Judicial Dedsionmaking in the Age of Biotechnolog, 13 NOTRE DAME J.L.
ETHICS & PUB. POL'Y 93, 96 (1999).
61 ALBERT R. JONSEN, supra note 22 at 158. See generally William M. Sage, The LawjeriZation of
Medine, 26 J. HEALTH POLITICS, POL'Y & 
L. 1179 (2001).
62 Id See also RUSSELL C. COILE, JR., THE NEW MEDICINE: RESHAPING MEDICAL PRACTICE AND
HEALTH CARE MANAGEMENT (1990).
63 JONSEN, sipra note 22. See general , George P. Smith, II, Uncertainties on the Spiral Staircase:
Metaethics and The Nex Biology, 41 THE PHAROS MED. J. 10 (1978); George P. Smith, II,
Manipulating The Genetic Code: Jurisprudential Conundrums, 64 GEO. L.J. 697 (1976).
64 JONSEN, supra note 22 at 1.
65 Meilaender, Case Studies: The Anencephalic Newborn as Donor, 16 HASTINGS CENTER RPT 23
(1986).
66 Edmund D. Pellegrino & David Thomasma, The Good of Patients and The Good of Society: Striking
a Moral Balance in PUBLIC HEALTH POLICY AND ETHICS at 17 (M. Boylan ed. 2004). See
Symposium, Public Health Ethics: Mapping the Terrain, 30 J. LAW MED. & ETHICS 170 (2004).
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Medicine. 67
Distinct from clinical medicine, which is directed toward healing and relieving
human suffering among individual patients, the medicine of society is concerned with
the use of medical knowledge to advance the health of society. 68 Yet, while these two
fields of medicine have differing ends, they enjoy a symbiotic relationship-this, because
"the end of each is essential for human well-being. 69 Advancing and pursuing health
care, then, is an obligation that "a good society owes its citizens in justice."' 70 A
balanced moral relationship between the goals of the individual patient and the common
good must always be sought.71 So long as this ethic and point of equilibrium guides the
development and use of the new medicine, the moral compass is set correctly and
humanely. Applying this ethic is always problematic, however, because "fiscal scarcity"
drives the new medical economics and forces a "general tightening of health care ethics
as government and business attempt to gain control over their skyrocketing
expenditures.
'72
67 Pellegrino & Thomasma, supra note 66 at 18.
68 Id
69 Id. at 21. Seegeneral/ GEORGEJ. ANNAS,JUDGING MEDICINE (1988).
7, Pellegrino & Thomasma, supra note 66 at 27. See ALAN CRIBB, HEALTH AND THE GOOD
SOCIETY (2005); George P. Smith, II, Human Rights and Bioetbics: Formulating a Universal Right to
Health, Health Care, or Health Protection, 39 VANDERBILTJ. TRANSNAT'L L. 1295 (2005).
71 Pellegrino & Thomasma, supra note 66 at 34. See RUSSELL HARDIN, TRUST AND
TRUSTWORTHINESS (2001); Barr, Reinventing in the Doctor-Patient Relationship in The Coming Age of
Scardy, 6 AM. J. BIOETHICS 33 (2006).
72 E. H. MORREIM, BALANCING ACT: THE NEW MEDICAL ETHICS OF MEDICINE'S NEW
ECONOMICS 50, 51 (1991). See JONATHAN HERRINGS, MEDICAL LAW AND ETHICS Ch. 9 (2006);
Alexander & Latos, The Doctor-Patient Relationship in The Post-Managed Care Era, 6 AM. J. BIOETHICS
29 (2006).
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